HILLEVAX INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of HilleVax, Inc. - HLVX

Group 1 - The proposed sale of HilleVax, Inc. to XOMA Royalty Corporation involves shareholders receiving $1.95 in cash per share, along with a non-transferable contingent value right for additional payments under certain conditions [1] - Kahn Swick & Foti, LLC is investigating whether the proposed consideration adequately reflects the value of HilleVax, indicating potential undervaluation [1] - The transaction is structured as a tender offer, emphasizing the importance of timely action for shareholders [3] Group 2 - Shareholders who believe the transaction undervalues HilleVax are encouraged to contact Kahn Swick & Foti for discussions regarding their legal rights [2] - Kahn Swick & Foti is led by former Louisiana Attorney General Charles C. Foti, Jr., highlighting the firm's legal expertise [3] - The investigation aims to ensure that the process leading to the proposed sale is fair and transparent for shareholders [1]